Skip to main content

2023 SSO Annual Meeting Main banner

Tweets by 2023 SSO Annual Meeting

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Speaker

Browse by Speaker

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

J
Jackson, Katherine

St. John's Cancer Institute
38: Semaphorin 4D is Expressed by Activated Lymphocytes in Pancreatic Adenocarcinoma, and Monoclonal Blockade Sensitizes Murine Tumors to Immune Checkpoint Therapy
Location:Ballroom B
Katherine Jackson
61: Smoking imparts shorter disease specific survival in patients with primary cutaneous melanoma
Location:Veterans Memorial Auditorium
Katherine Jackson
P45: Dietary fish oil impairs melanoma growth and augments the tumor immune microenvironment in anti-PD-1 treated melanoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Katherine Jackson
Jafari, Mehraneh

Weill Cornell Medical College
P17: Trends in the Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Mehraneh Jafari
Jagasia, Madan

Iovance Biotherapeutics, Inc., San Carlos, CA, USA
64: Lifileucel TIL Cell Therapy in Patients With Advanced Melanoma After Progression on Immune Checkpoint Inhibitors (ICI) and Targeted Therapy: Tumor Tissue Procurement Data from the C-144-01 Study
Location:Veterans Memorial Auditorium
Madan Jagasia
Jain, Abhishek

Yale University School of Public Health
20: Multi-omic Analysis Reveals Potential Mechanisms of EGFR-inhibitor Resistance in Right Sided Colon Cancer Liver Metastases
Location:Veterans Memorial Auditorium
Abhishek Jain
Jakub, James

Mayo Clinic
4: Germline Genetic Mutations in a Prospective Multi-Center Cohort of 241 Phyllodes Tumors; Time to Expand Testing Criteria
Location:Veterans Memorial Auditorium
James Jakub
Janczewski, Lauren

Northwestern University Feinberg School of Medicine
P71: Are Pathologic Factors Associated with Higher Risk for Venous Thromboembolism After Gastrointestinal Cancer Surgery? A Potential Opportunity to Tailor Prophylaxis
Location:SSO HUB: Rare/Metastatic Cancers Zone
Lauren Janczewski
Janjigian, Yelena

Memorial Sloan Kettering Cancer Center
P82: Short- and Long- Term Outcomes of Minimally Invasive vs Open Gastrectomy after Neoadjuvant Chemotherapy for Gastric cancer.
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Yelena Janjigian
Januszyk, Michael

Stanford University
39: Mechanoresponsive Pancreatic Ductal Adenocarcinoma Cancer Associated Fibroblasts Shows an FAK-Dependent Subtype Divergent from Canonical Fibrotic TGFB-Pathway Dependence
Location:Ballroom B
Michael Januszyk
Jarnagin, William

Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center
27: The Prognostic Value of Pre- and Post-Neoadjuvant Chemotherapy Serum Carcinoembryonic Antigen Levels in Patients Having Resection of Colorectal Liver Metastases
Location:Ballroom C
William Jarnagin
35: Genetic Heterogeneity of Intrahepatic Cholangiocarcinoma: Implications for Outcome
Location:Veterans Memorial Auditorium
William Jarnagin
37: Hepatic Artery Infusion Chemotherapy Compared to Y90 for Treatment of Unresectable Colorectal Liver Metastases: A Multi-Institutional Comparative Study
Location:Ballroom B
William Jarnagin
52: Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage.
Location:Ballroom A
William Jarnagin
Jason, Wang

University of North Carolina
29: Development of a novel PET agent for parathyroid imaging targeting the Calcium-Sensing Receptor (CaSR)
Location:Ballroom A
Wang Jason
Javid, Mahsa

University of Louisville
Challenging Cases in Parathyroid Disease
Location:SSO HUB: Breast & Endocrine Zone
Mahsa Javid
Jelinek, Jaroslav

Coriell Institute for Medical Research
10: Epigenetic Drug Therapy Increases Immune Activation and Expression of Genes in the Oncotype Dx Score in Breast Cancer
Location:Veterans Memorial Auditorium
Jaroslav Jelinek
Jeong, Irene

University of Toronto
P16: The role of anastomotic leak as a potential high-risk criteria in Stage II colon cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Irene Jeong
Jeong, Joon

Gangnam Severance Hospital
Between Patient and Policy Maker - What We Can do to Build Global Capacity for Cancer Surgery
Location:Ballroom A
Joon Jeong
Jerath, Angela

University of Toronto
84: The association between familiarity of the surgeon-anesthesiologist dyad and post-operative patient outcomes for complex gastrointestinal cancer surgery: a population-based study.
Location:Ballroom B
Angela Jerath
Jewell, Rachel

University of Rochester Medical Center
38: Semaphorin 4D is Expressed by Activated Lymphocytes in Pancreatic Adenocarcinoma, and Monoclonal Blockade Sensitizes Murine Tumors to Immune Checkpoint Therapy
Location:Ballroom B
Rachel Jewell
44: Pten deletion-induced murine model of cholangiocarcinoma: a pathologic and immune analysis
Location:Ballroom B
Rachel Jewell
46: Pan-Lysyl Oxidase Inhibition Disrupts Macrophage Invasion and Renders Tumor-Associated Macrophages Susceptible to Cytotoxic Chemotherapy in Cholangiocarcinoma
Location:Ballroom A
Rachel Jewell
P45: Dietary fish oil impairs melanoma growth and augments the tumor immune microenvironment in anti-PD-1 treated melanoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Rachel Jewell
Johnson, Caroline

Yale School of Public Health
20: Multi-omic Analysis Reveals Potential Mechanisms of EGFR-inhibitor Resistance in Right Sided Colon Cancer Liver Metastases
Location:Veterans Memorial Auditorium
Caroline Johnson
Johnson, Helen

MD Anderson Cancer Center
7: Multicenter clinical trial for omission of breast surgery in invasive cancer following neoadjuvant systemic therapy: Longitudinal patient reported outcomes and decisional comfort planned analyses
Location:Veterans Memorial Auditorium
Helen Johnson
Johnson, Jocelyn

University of Colorado Cancer Center
P77: Prospective Evaluation of a Universally Applied Laparoscopic Gastric Ischemic Preconditioning Protocol Prior to Esophagectomy with Comparison to Historical Controls
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Jocelyn Johnson
Johnson, Josh

New York-Presbyterian Weill Cornell Medicine
P8: Breast Cancer Among Asian Women in New York City: Disparities in Presentation and the Need for Disaggregated Data
Location:SSO HUB: Breast & Endocrine Zone
Josh Johnson
Johnson, Lauren

University of Arkansas for Medical Sciences
83: Adherence to and outcomes of extended venous thromboembolism prophylaxis after complex gastrointestinal cancer surgery
Location:Veterans Memorial Auditorium
Lauren Johnson
Johnson, Nathalie
Panel: Pursuing a Career in Academia Versus Private Practice
Location:Room 302
Nathalie Johnson
Johnston, Fabian

Johns Hopkins University
28: Tumor Deposits Are Associated with a Higher Risk of Peritoneal Disease in Non-Metastatic Colorectal Cancer Patients
Location:Ballroom C
Fabian Johnston
71: Intra-and interpatient drug response heterogeneity exist in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastrointestinal cancers
Location:Ballroom B
Fabian Johnston
PSM Poster Presentations 2
Location:SSO HUB: Rare/Metastatic Cancers Zone
Fabian Johnston
Jones, Heather

University of Pittsburgh Medical Center
P56: A Data Driven Approach for Individualized Risk Prediction of Serious Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Location:SSO HUB: Rare/Metastatic Cancers Zone
Heather Jones
Jones, Peter

St John's Cancer Institute
61: Smoking imparts shorter disease specific survival in patients with primary cutaneous melanoma
Location:Veterans Memorial Auditorium
Peter Jones
Judge, Sean

Department of Surgery, University of California, Davis
P37: Characterization of Natural Killer and Cytotoxic T Cell Immune Infiltrates in Pancreatic Ductal Adenocarcinoma
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Sean Judge
Juhel, Brooke

Massachusetts General Hospital
9: Breast cancer-related lymphedema and its relationship to major landmark trials in surgical oncology and radiation oncology
Location:Veterans Memorial Auditorium
Brooke Juhel
Ju, Michelle

UT Southwestern
96: Serum IL-6 level predicts survival and treatment response in gastric and gastroesophageal junction cancer
Location:Ballroom A
Michelle Ju
Jung, Sin-Ho

Duke University
58: Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?
Location:Veterans Memorial Auditorium
Sin-Ho Jung
Jun, John

UC San Diego
76: Single nuclei RNAseq Reveals Dedifferentiation States from Human ICCs to GIST
Location:Ballroom A
John Jun
Jurdi, Adham

Natera
P33: Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Adham Jurdi
Ju, Tammy

New York-Presbyterian Queens
P8: Breast Cancer Among Asian Women in New York City: Disparities in Presentation and the Need for Disaggregated Data
Location:SSO HUB: Breast & Endocrine Zone
Tammy Ju